Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    4 Takeaways From A Special Subway Series In The Bronx

    Washington scrambles to act while window closes

    New guidelines on size, design of waiting bays for delivery riders

    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest VKontakte
    Sg Latest NewsSg Latest News
    • Home
    • Politics
    • Business
    • Technology
    • Entertainment
    • Health
    • Sports
    Sg Latest NewsSg Latest News
    Home»Health»Boulder Sterilization Exec Speaks at Sterilization Summit 2025
    Health

    Boulder Sterilization Exec Speaks at Sterilization Summit 2025

    AdminBy AdminNo Comments
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    — Industry expert evaluates alternative sterilization methods —

    BOULDER, Colo., Oct. 15, 2025 /PRNewswire/ — Jim Kasic of Boulder Sterilization will be a featured speaker at next week’s Sterilization Summit USA 2025 in Anaheim, California.

    Kasic is president and CEO of the Boulder BioMed family of companies, including Boulder Sterilization. Boulder BioMed is a group of expert contract consulting businesses providing all the services life sciences companies need to get their products to market. Boulder Sterilization provides quick-turn ethylene oxide (EO) and chlorine dioxide (CD) sterilization, final assembly and packaging services.

    Speaker topic: Alternative sterilization methods
    Kasic, a medical device sterilization expert, will present “The Growing Acceptance and Adoption of Alternative Sterilization Methods” Tuesday, Oct. 21. In his talk, he will cover:

    • Accelerating sterilization validation processes: Impact on the product-development pathway
    • Elimination of harmful residues, how to reduce community safety risks in processing
    • Introduction of EO-to-CD conversion systems that enable cleaner sterilization pathways

    Panel discussion: Optimizing sterilization processes
    Kasic will also participate in a panel discussion on “Optimizing Sterilization Practices in Healthcare Organizations” Monday, Oct. 20. The panel will review:

    • Replacement of outdated disinfection norms with sterilization-first protocols to reduce costs
    • Multi-modal sterilization pathways for device returns and pharma preparation
    • Reassessment of Spaulding guidance; advancement of sterile processing department safety under budget constraints
    • Guidance to developers on validation, prototyping and optimization in sterilization design
    • Evaluation of hospital sterilization gaps, risks and tech-driven strategies for efficiency

    Given the U.S. Environmental Protection Agency’s 2024 ruling that put in place strong measures for EO commercial sterilization facilities, medical device developers used to sterilizing with EO are understandably concerned about its use and cost going forward, says Kasic. “Understanding EO alternatives, particularly chlorine dioxide, is critical for developments looking to speed their products to market while minimizing safety risks.”

    Sterilization Summit brings together healthcare leaders and sterilization experts to explore the latest technologies and innovations advancing patient safety and infection prevention. Participants share insights and discuss the latest advancements in sterilization as they work to create a safer, more sustainable future in healthcare. 

    Boulder BioMed
    The Boulder BioMed family is a group of expert contract consulting businesses that provide life sciences companies all the services they need to bring products to market. Boulder BioMed provides a single source for device developers, providing full product development under one roof: ideation, design, engineering, manufacturing, sterilization and packaging, and regulatory affairs and quality assurance.

    Boulder BioMed is based in Boulder, Colorado, and is ISO 13485-certified, with packaging testing, including shipping validation, per ASTM D4169 and ISTA 3A.

    Media contact: Aimee Bennett, [email protected], 303-843-9840

    SOURCE Boulder Sterilization

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Admin
    • Website

    Related Posts

    Sacituzumab Govitecan Plus Pembrolizumab Does Not Meet Primary Endpoints in First-Line PD-L1-High Metastatic NSCLC

    Want to lower your risk of dementia? It doesn’t involve a blood test

    Trump administration to send $500 payments to nearly 1 million Obamacare participants

    10 Science-Backed Tips to Achieve Natural Fat Burn

    Add A Comment
    Leave A Reply Cancel Reply

    Editors Picks

    Singapore overtaken by Ningbo-Zhoushan as second busiest container port in H1

    As supply shocks multiply, monetary policy will shape corporate resilience

    Apple Watch Series 12 features leaked ahead of Apple’s fall event

    Sg Latest News
    Facebook X (Twitter) Instagram Pinterest Vimeo YouTube
    • Get In Touch
    © 2026 SglatestNews. All rights reserved.

    Type above and press Enter to search. Press Esc to cancel.